Inspection Record

Boston Scientific Corporation — FDA 483 Findings

US FDAInspected 2015-07-24Published 2024-01-17 7 findingsDeviation, CAPA, and investigationTraining and personnelOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Deviation, CAPA, and investigation

Corrective and preventive action activities have not been documented, including investigations ofcauses ofnonconformities, the actions needed to correct or prevent recutrence ofnonconforming product and other quality problems, and implementation ofcorrective and preventive actions, OF THIS PAGE > IGE: et Deed AM) PHO: Une ; eM AND a aAree oN TT he = | | Stoneham, MA 02180 —— , A.

2Training and personnel

Specifically, the training filé fora Distribution Aesaciate/Overstock and Replenishment employeeSBE _ | does not show documentation of training on procedures relating to everyday job duties.

3Other quality system

Corrective and preventive actions have not been verified or validated to ensure that the action is effective and does nct niversely affect the finished device.

4Other quality system

Specifically, PIR USD 2005-01-01, Part IIIA, Global Medical/Clinical Assessment, did not answerthe question from the Detection section appropriately.

5Deviation, CAPA, and investigation

The corrective and preventive action procedures addressing the investigation of the cause of nonconfommities relating to Product, processes, and the qualitysystem were notimplemented.

6Training and personnel

Employee training is not fully documented.

7Other quality system

Required records are not retained for at feast 2 years from the date of release of the device for commercial distribution Specifically, the Emergency FREP Pull Lists, otherwise known as the ZV29 Forms, are discarded.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Boston Scientific Corporation company profile — full history US FDA documents, 2024 Go to Findings search